BMED vs SCHD
iShares Health Innovation Active ETF vs Schwab US Dividend Equity ETF
Which is better, BMED or SCHD?
All Cap Blend against Large Cap Value.
SCHD has a lower expense ratio. SCHD led over 1Y, 3Y, 5Y and the full window. SCHD is less concentrated, with 41.5% of the fund in its ten largest positions against 43.1%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BMED | SCHD |
|---|---|---|
| Expense Ratio | 0.55% | 0.06%Best |
| AUM | $14M | $112.2B |
| Dividend Yield | 0.26% | 3.13% |
| Holdings | 61 | 103 |
| YTD Return | +12.45% | +27.56%Best |
| 1Y Return | +29.03% | +30.29%Best |
| 3Y Return (annualized) | +12.81% | +16.37%Best |
| 5Y Return (annualized) | +2.02% | +10.23%Best |
| Volatility (annualized) | 17.1% | 15.2%Best |
| Max Drawdown | -36.4% | -16.9%Best |
| $10,000 over 5 years | $11,052 | $16,274Best |
| Top 10 Weight | 43.1% | 41.5%Best |
| Fund Family | BlackRock, Inc. (US) | Charles Schwab Asset Management |
| Category | Equity | Equity |
| Style | All Cap Blend | Large Cap Value |
| Inception | Sep 29, 2020 | Oct 20, 2011 |
Volatility and max drawdown are measured over the window both funds cover: Oct 1, 2020 to Sep 4, 2026 (5.9 years).
BMED vs SCHD growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 5.9 years both funds cover.
BMED vs SCHD Performance
iShares Health Innovation Active ETF (BMED) is an ETF from BlackRock, Inc. (US) and Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management. Over the past year BMED returned +29.03% while SCHD returned +30.29%. Year to date, BMED is up 12.45% versus a gain of 27.56% for SCHD.
Over three years, BMED compounded at +12.81% per year against +16.37% for SCHD; over five years the annualized figures are +2.02% and +10.23% respectively. Across the full 6-year window we track, SCHD has the edge at +15.01% annualized vs +5.03%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BMED has been the more volatile fund, with annualized monthly volatility of 17.1% compared with 15.2% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -36.4% for BMED and -16.9% for SCHD. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.59. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BMED charges 0.55% per year while SCHD charges 0.06%. On a $10,000 position that is $55 vs $6 annually, a gap of $49 per year that compounds over a long holding period. On income, BMED currently yields 0.26% against 3.13% for SCHD.
Holdings Overlap
11.3% of BMED's money is in holdings SCHD also owns. 16.9% of SCHD's money is in holdings BMED also owns.
SCHD and BMED share little of their money.
4 positions in common, counted across the 53 positions we hold weights for in BMED and 100 in SCHD, against full books of 61 and 103.
What only one of them owns
Our book lists 95 positions for SCHD that do not appear in our book for BMED (83.0% of the fund), and 40 for BMED that do not appear in SCHD (79.8%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
You are not choosing between two funds in isolation.
Whichever of BMED and SCHD you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BMED or SCHD?
BMED has an expense ratio of 0.55% while SCHD charges 0.06%. SCHD is the cheaper option, by $49 a year on a $10,000 investment.
Which performed better, BMED or SCHD?
Over the past year BMED returned +29.03% vs +30.29% for SCHD, so SCHD leads on 1-year performance. Over the longest common window we track (6 years), BMED annualized +5.03% vs +15.01% for SCHD. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BMED or SCHD?
BMED has been the more volatile fund at 17.1% annualized versus 15.2% for SCHD. Worst drawdown: BMED -36.4% vs SCHD -16.9%.
Should I hold both BMED and SCHD?
BMED and SCHD have a monthly-return correlation of 0.59, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BMED and SCHD?
16.9% of SCHD's money is in holdings BMED also owns. 16.9% of SCHD's is in holdings BMED also owns. They hold 4 positions in common, counted across the 53 positions we hold weights for in BMED and 100 in SCHD.
Which pays a higher dividend, BMED or SCHD?
BMED yields 0.26% while SCHD yields 3.13%, so SCHD currently pays the higher dividend yield.
Is SCHD better than BMED?
SCHD has a lower expense ratio. SCHD led over 1Y, 3Y, 5Y and the full window. SCHD is less concentrated, with 41.5% of the fund in its ten largest positions against 43.1%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.